世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000038465

徐放性賦形剤市場調査レポートー2032年までの市場予測

Market Research Future

Sustained Release Excipients Market Research Report - Market Forecast to 2032

発刊日 2024/05

言語英語

体裁PDF/128ページ

ライセンス/価格128ページ

0000038465

Single
Multiuser
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※章ごとの販売価格はシングルユーザーライセンスのものとなります。他のライセンス形態・価格に関しましてはご相談下さい。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

徐放性賦形剤市場調査レポート:製品タイプ別情報 (ゼラチン、ポリマー、ミネラル、糖など)、投与経路別(経口、筋肉内、皮下、経皮、静脈内、その他)、技術別(標的送達、マイクロカプセル化、ウルスター技術など)、地域別(北米、欧州、アジア太平洋、その他の地域)-2032年までの市場予測

徐放性賦形剤世界市場の概要

徐放性賦形剤の市場規模は、2023年に14億ドルと評価されました。この市場は、2024年の15億ドルから2032年までに25億ドルに成長し、予測期間(2024年から2032年)の間に8.00%のCAGRを示すと予測されます。市場の推進要因には、特許切れの頻度の増加や、小児および老年集団の剤形の必要性の高まりなどがあり、これらは徐放性賦形剤市場の拡大に大きな影響を与えています。

レポート詳細

目次

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations

3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation

4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities

5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis

6. GLOBAL SUSTAINED RELEASE EXCIPIENTS MARKET, BY PRODUCT TYPE
6.1. Overview
6.2. Gelatin
6.3. Polymers
6.4. Minerals
6.5. Sugars
6.6. Others

7. GLOBAL SUSTAINED RELEASE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION
7.1. Overview
7.2. Oral
7.3. Intramuscular
7.4. Subcutaneous
7.5. Transdermal
7.6. Intravenous
7.7. Others

8. GLOBAL SUSTAINED RELEASE EXCIPIENTS MARKET, BY TECHNOLOGY
8.1. Overview
8.2. Targeted Delivery
8.3. Microencapsulation
8.4. Wurster Technique
8.5. Others

9. GLOBAL SUSTAINED RELEASE EXCIPIENTS MARKET, BY REGION
9.1. Overview
9.1. North America
9.1.1. US
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. France
9.2.3. UK
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia-Pacific
9.3.1. China
9.3.2. India
9.3.3. Japan
9.3.4. South Korea
9.3.5. Australia
9.3.6. Rest of Asia-Pacific
9.4. Rest of the World
9.4.1. Middle East
9.4.2. Africa
9.4.3. Latin America

10. COMPETITIVE LANDSCAPE
10.1. Overview
10.2. Competitive Analysis
10.3. Market Share Analysis
10.4. Major Growth Strategy in the Global Sustained Release Excipients Market,
10.5. Competitive Benchmarking
10.6. Leading Players in Terms of Number of Developments in the Global Sustained Release Excipients Market,
10.7. Key developments and Growth Strategies
10.7.1. New Product Launch/Service Deployment
10.7.2. Merger & Acquisitions
10.7.3. Joint Ventures
10.8. Major Players Financial Matrix
10.8.1. Sales & Operating Income, 2023
10.8.2. Major Players R&D Expenditure. 2023

11. COMPANY PROFILES
11.1. Allergan PLC
11.1.1. Company Overview
11.1.2. Financial Overview
11.1.3. Products Offered
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. AstraZeneca
11.2.1. Company Overview
11.2.2. Financial Overview
11.2.3. Products Offered
11.2.4. Key Developments
11.2.5. SWOT Analysis
11.2.6. Key Strategies
11.3. GlaxoSmithKline PLC
11.3.1. Company Overview
11.3.2. Financial Overview
11.3.3. Products Offered
11.3.4. Key Developments
11.3.5. SWOT Analysis
11.3.6. Key Strategies
11.4. Mayne Pharma Group Limited
11.4.1. Company Overview
11.4.2. Financial Overview
11.4.3. Products Offered
11.4.4. Key Developments
11.4.5. SWOT Analysis
11.4.6. Key Strategies
11.5. Mylan NV
11.5.1. Company Overview
11.5.2. Financial Overview
11.5.3. Products Offered
11.5.4. Key Developments
11.5.5. SWOT Analysis
11.5.6. Key Strategies
11.6. Novartis AG
11.6.1. Company Overview
11.6.2. Financial Overview
11.6.3. Products Offered
11.6.4. Key Developments
11.6.5. SWOT Analysis
11.6.6. Key Strategies
11.7. Pfizer Inc.
11.7.1. Company Overview
11.7.2. Financial Overview
11.7.3. Products Offered
11.7.4. Key Developments
11.7.5. SWOT Analysis
11.7.6. Key Strategies
11.8. Salix Pharmaceuticals
11.8.1. Company Overview
11.8.2. Financial Overview
11.8.3. Products Offered
11.8.4. Key Developments
11.8.5. SWOT Analysis
11.8.6. Key Strategies
11.9. Sun Pharmaceutical Industries Ltd.
11.9.1. Company Overview
11.9.2. Financial Overview
11.9.3. Products Offered
11.9.4. Key Developments
11.9.5. SWOT Analysis
11.9.6. Key Strategies

12. APPENDIX
12.1. References
12.2. Related Reports

LIST OF TABLES
TABLE 1 GLOBAL SUSTAINED RELEASE EXCIPIENTS MARKET, SYNOPSIS, 2019-2032
TABLE 2 GLOBAL SUSTAINED RELEASE EXCIPIENTS MARKET, ESTIMATES & FORECAST, 2019-2032 (USD BILLION)
TABLE 3 GLOBAL SUSTAINED RELEASE EXCIPIENTS MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 4 GLOBAL SUSTAINED RELEASE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLION)
TABLE 5 GLOBAL SUSTAINED RELEASE EXCIPIENTS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 6 NORTH AMERICA: SUSTAINED RELEASE EXCIPIENTS MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 7 NORTH AMERICA: SUSTAINED RELEASE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLION)
TABLE 8 NORTH AMERICA: SUSTAINED RELEASE EXCIPIENTS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 9 US: SUSTAINED RELEASE EXCIPIENTS MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 10 US: SUSTAINED RELEASE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLION)
TABLE 11 US: SUSTAINED RELEASE EXCIPIENTS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 12 CANADA: SUSTAINED RELEASE EXCIPIENTS MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 13 CANADA: SUSTAINED RELEASE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLION)
TABLE 14 CANADA: SUSTAINED RELEASE EXCIPIENTS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 1 EUROPE: SUSTAINED RELEASE EXCIPIENTS MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 2 EUROPE: SUSTAINED RELEASE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLION)
TABLE 3 EUROPE: SUSTAINED RELEASE EXCIPIENTS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 4 GERMANY: SUSTAINED RELEASE EXCIPIENTS MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 5 GERMANY: SUSTAINED RELEASE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLION)
TABLE 6 GERMANY: SUSTAINED RELEASE EXCIPIENTS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 7 FRANCE: SUSTAINED RELEASE EXCIPIENTS MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 8 FRANCE: SUSTAINED RELEASE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLION)
TABLE 9 FRANCE: SUSTAINED RELEASE EXCIPIENTS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 10 ITALY: SUSTAINED RELEASE EXCIPIENTS MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 11 ITALY: SUSTAINED RELEASE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLION)
TABLE 12 ITALY: SUSTAINED RELEASE EXCIPIENTS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 13 SPAIN: SUSTAINED RELEASE EXCIPIENTS MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 14 SPAIN: SUSTAINED RELEASE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLION)
TABLE 15 SPAIN: SUSTAINED RELEASE EXCIPIENTS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 16 UK: SUSTAINED RELEASE EXCIPIENTS MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 17 UK: SUSTAINED RELEASE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLION)
TABLE 18 UK: SUSTAINED RELEASE EXCIPIENTS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 19 REST OF EUROPE: SUSTAINED RELEASE EXCIPIENTS MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 20 REST OF EUROPE: SUSTAINED RELEASE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLION)
TABLE 21 REST OF EUROPE: SUSTAINED RELEASE EXCIPIENTS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 22 ASIA-PACIFIC: SUSTAINED RELEASE EXCIPIENTS MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 23 ASIA-PACIFIC: SUSTAINED RELEASE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLION)
TABLE 24 ASIA-PACIFIC: SUSTAINED RELEASE EXCIPIENTS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 25 JAPAN: SUSTAINED RELEASE EXCIPIENTS MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 26 JAPAN: SUSTAINED RELEASE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLION)
TABLE 27 JAPAN: SUSTAINED RELEASE EXCIPIENTS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 28 CHINA: SUSTAINED RELEASE EXCIPIENTS MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 29 CHINA: SUSTAINED RELEASE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLION)
TABLE 30 CHINA: SUSTAINED RELEASE EXCIPIENTS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 31 INDIA: SUSTAINED RELEASE EXCIPIENTS MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 32 INDIA: SUSTAINED RELEASE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLION)
TABLE 33 INDIA: SUSTAINED RELEASE EXCIPIENTS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 34 AUSTRALIA: SUSTAINED RELEASE EXCIPIENTS MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 35 AUSTRALIA: SUSTAINED RELEASE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLION)
TABLE 36 AUSTRALIA: SUSTAINED RELEASE EXCIPIENTS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 37 SOUTH KOREA: SUSTAINED RELEASE EXCIPIENTS MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 38 SOUTH KOREA: SUSTAINED RELEASE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLION)
TABLE 39 SOUTH KOREA: SUSTAINED RELEASE EXCIPIENTS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 40 REST OF ASIA-PACIFIC: SUSTAINED RELEASE EXCIPIENTS MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 41 REST OF ASIA-PACIFIC: SUSTAINED RELEASE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLION)
TABLE 42 REST OF ASIA-PACIFIC: SUSTAINED RELEASE EXCIPIENTS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 43 REST OF THE WORLD: SUSTAINED RELEASE EXCIPIENTS MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 44 REST OF THE WORLD: SUSTAINED RELEASE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLION)
TABLE 45 REST OF THE WORLD: SUSTAINED RELEASE EXCIPIENTS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 46 MIDDLE EAST: SUSTAINED RELEASE EXCIPIENTS MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 47 MIDDLE EAST: SUSTAINED RELEASE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLION)
TABLE 48 MIDDLE EAST: SUSTAINED RELEASE EXCIPIENTS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 49 AFRICA: SUSTAINED RELEASE EXCIPIENTS MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 50 AFRICA: SUSTAINED RELEASE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLION)
TABLE 51 AFRICA: SUSTAINED RELEASE EXCIPIENTS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 52 LATIN AMERICA: SUSTAINED RELEASE EXCIPIENTS MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 53 LATIN AMERICA: SUSTAINED RELEASE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLION)
TABLE 54 LATIN AMERICA: SUSTAINED RELEASE EXCIPIENTS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL SUSTAINED RELEASE EXCIPIENTS MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL SUSTAINED RELEASE EXCIPIENTS MARKET
FIGURE 4 GLOBAL SUSTAINED RELEASE EXCIPIENTS MARKET, SHARE (%), BY PRODUCT TYPE, 2023
FIGURE 5 GLOBAL SUSTAINED RELEASE EXCIPIENTS MARKET, SHARE (%), BY ROUTE OF ADMINISTRATION, 2023
FIGURE 6 GLOBAL SUSTAINED RELEASE EXCIPIENTS MARKET, SHARE (%), BY TECHNOLOGY, 2023
FIGURE 7 GLOBAL SUSTAINED RELEASE EXCIPIENTS MARKET, SHARE (%), BY REGION, 2023
FIGURE 8 NORTH AMERICA: SUSTAINED RELEASE EXCIPIENTS MARKET, SHARE (%), BY REGION, 2023
FIGURE 9 EUROPE: SUSTAINED RELEASE EXCIPIENTS MARKET, SHARE (%), BY REGION, 2023
FIGURE 10 ASIA-PACIFIC: SUSTAINED RELEASE EXCIPIENTS MARKET, SHARE (%), BY REGION, 2023
FIGURE 11 REST OF THE WORLD: SUSTAINED RELEASE EXCIPIENTS MARKET, SHARE (%), BY REGION, 2023
FIGURE 12 GLOBAL SUSTAINED RELEASE EXCIPIENTS MARKET: COMPANY SHARE ANALYSIS, 2023 (%)
FIGURE 13 ALLERGAN PLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 14 ALLERGAN PLC: SWOT ANALYSIS
FIGURE 15 ASTRAZENECA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 16 ASTRAZENECA: SWOT ANALYSIS
FIGURE 17 GLAXOSMITHKLINE PLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 18 GLAXOSMITHKLINE PLC: SWOT ANALYSIS
FIGURE 19 MAYNE PHARMA GROUP LIMITED: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 20 MAYNE PHARMA GROUP LIMITED: SWOT ANALYSIS
FIGURE 21 MYLAN NV: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 MYLAN NV: SWOT ANALYSIS
FIGURE 23 NOVARTIS AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 NOVARTIS AG: SWOT ANALYSIS
FIGURE 25 PFIZER INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 PFIZER INC.: SWOT ANALYSIS
FIGURE 27 SALIX PHARMACEUTICALS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 SALIX PHARMACEUTICALS: SWOT ANALYSIS
FIGURE 29 SUN PHARMACEUTICAL INDUSTRIES LTD.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 SUN PHARMACEUTICAL INDUSTRIES LTD.: SWOT ANALYSIS

この商品のレポートナンバー

0000038465

TOP